Hiroshi Miyata

Overexpression of miR-200c Induces Chemoresistance in Esophageal Cancers Mediated Through Activation of the Akt Signaling Pathway

Rie Hamano, Hiroshi Miyata, Makoto Yamasaki et al. · Clinical Cancer Research · 2011 · 245 citations · Full text

Medicine, Molecular Biology, Oncology +17

Regulation of Interleukin-1β-induced Interleukin-6 Gene Expression in Human Fibroblast-like Synoviocytes by p38 Mitogen-activated Protein Kinase

Keiji Miyazawa, Akio Mori, Hiroshi Miyata et al. · Journal of Biological Chemistry · 1998 · 225 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Let-7 Expression Is a Significant Determinant of Response to Chemotherapy through the Regulation of IL-6/STAT3 Pathway in Esophageal Squamous Cell Carcinoma

Keijiro Sugimura, Hiroshi Miyata, Koji Tanaka et al. · Clinical Cancer Research · 2012 · 156 citations

Medicine, Cancer Biology, Oncology +17

Identification of Febuxostat as a New Strong ABCG2 Inhibitor: Potential Applications and Risks in Clinical Situations

Hiroshi Miyata, Tappei Takada, Yu Toyoda et al. · Frontiers in Pharmacology · 2016 · 146 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +15

Effects of Ghrelin Administration After Total Gastrectomy: A Prospective, Randomized, Placebo-Controlled Phase II Study

Shin‐ichi Adachi, Shuji Takiguchi, Kazuyuki Okada et al. · Gastroenterology · 2010 · 139 citations

Medicine, Endocrinology, Surgery +9